AQS — Aequus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Aequus Pharmaceuticals filed clinical trial application with Health Canada
Brief: Aequus Pharmaceuticals enters into agreement with Santen Pharmaceutical's unit
Brief: Aequus Pharmaceuticals launches medical cannabis physician research in U.S. and Canada
Brief: Aequus says upsizing of previously announced bought deal of units to $4.5 mln
Brief: Aequus announces $3 mln bought deal financing
Brief: Aequus expects to report topline results from multi-dose study in Q1
Brief: Aequus says initiates second proof of concept clinical trial of transdermal aripiprazole patch
Brief: Aequus advances clinical development of Transdermal Aripiprazole Patch
Brief: Aequus partners with Camargo to support US regulatory strategy for development programs
Brief: Aequus provides corporate update on commercial and development programs
Brief: Aequus announces advancement of anti-nausea transdermal extended-release patent application
Brief: Aequus Pharmaceuticals says advancement of clobazam transdermal patent application
Brief: Aequus appoints Ann Fehr as chief financial officer
Brief: Aequus Pharmaceuticals announces stock option grant
Brief: Aequus announces positive results from its study